Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review.
Jahnvi DharJayanta SamantaZaheer NabiManik AggarwalAntonio FacciorussoMaria Cristina Conti BellocchiStefano Francesco CrinòPublished in: Expert review of gastroenterology & hepatology (2024)
EUS-RFA is being advocated as a 'mini-invasive' option with the potential to replace surgery as a first-line approach for benign, sporadic, solitary, and small (<2 cm) insulinomas. Under real-time guidance, EUS-RFA has immense precision, is safe, predictable, with acceptable safety profile. Presently, it is being frequently performed for high-risk or inoperable candidates. Current need-of-the-hour is a randomized controlled trial to substantiate its role in the therapeutic algorithm for insulinoma management.
Keyphrases
- radiofrequency ablation
- ultrasound guided
- fine needle aspiration
- minimally invasive
- coronary artery bypass
- machine learning
- blood pressure
- late onset
- deep learning
- amyotrophic lateral sclerosis
- surgical site infection
- locally advanced
- squamous cell carcinoma
- risk assessment
- radiation therapy
- percutaneous coronary intervention
- rare case
- early onset
- climate change